Literature DB >> 1704432

Biphasic reduction and concanavalin A binding properties of serum alpha-fetoprotein in preterm and term infants.

P Lahdenne1, P Kuusela, M A Siimes, K A Rönnholm, L Salmenperä, M Heikinheimo.   

Abstract

Reference values for postnatal serum alpha-fetoprotein (AFP) and concanavalin A (ConA) binding subfractions of AFP in preterm and term infants are presented. Preterm infants had 10-fold higher serum concentrations of AFP than did term infants at birth. The reduction of serum values of AFP was biphasic in both groups and differed significantly between the two groups. The first declining phase continued for approximately 4 months in preterm and for 2 months in term infants, and was related to the degree of prematurity. The AFP values reached adult levels by 12 months in preterm and by 9 months in term infants. The developmental pattern of the carbohydrate moiety of AFP was determined by ConA fractioning. The proportion of the ConA nonreactive subfraction of AFP in preterm and term infants at birth was 6% and 13%, respectively; it increased more rapidly in term than in preterm infants but reached 85% to 95% by the age of 6 months in both infant groups. Our results indicate that the postnatal maturation of AFP synthesis is dependent on gestational age. Malignant recurrences of neonatal sacrococcygeal teratomas were associated with an increase in serum concentration of AFP and a decrease in the proportion of the ConA nonreactive subfraction of AFP.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1704432     DOI: 10.1016/s0022-3476(05)80501-3

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  6 in total

1.  Development of the Serum α-Fetoprotein Reference Range in Patients with Beckwith-Wiedemann Spectrum.

Authors:  Kelly A Duffy; Jennifer L Cohen; Okan U Elci; Jennifer M Kalish
Journal:  J Pediatr       Date:  2019-06-22       Impact factor: 4.406

2.  Tumor markers AFP, CA 125, and CA 19-9 in the long-term follow-up of sacrococcygeal teratomas in infancy and childhood.

Authors:  Satu-Liisa Pauniaho; Olga Tatti; Pekka Lahdenne; Harry Lindahl; Mikko Pakarinen; Risto Rintala; Markku Heikinheimo
Journal:  Tumour Biol       Date:  2010-04-02

Review 3.  Current strategies for the treatment of hereditary tyrosinemia type I.

Authors:  Merja Ashorn; Sari Pitkänen; Matti K Salo; Markku Heikinheimo
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

Review 4.  Overview of pediatric testicular tumors in Korea.

Authors:  Jae Min Chung; Sang Don Lee
Journal:  Korean J Urol       Date:  2014-12-05

5.  Type 1 tyrosinemia in Finland: a nationwide study.

Authors:  Linnea Äärelä; Pauliina Hiltunen; Tea Soini; Nina Vuorela; Heini Huhtala; Pasi I Nevalainen; Markku Heikinheimo; Laura Kivelä; Kalle Kurppa
Journal:  Orphanet J Rare Dis       Date:  2020-10-12       Impact factor: 4.123

6.  Human Epididymis Protein 4 Levels in Neonates with Respiratory Disorder.

Authors:  Piotr Surmiak; Martyna Szymkowiak; Małgorzata Baumert
Journal:  Biomed Res Int       Date:  2020-04-02       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.